PERSONAL AND FAMILY CLINICAL HISTORY (anamnesis)
- Ultrasound scan
- Breast examination
- Consisting of a psychological test and a visit from our team of psychologists, enabling us to rule out any pathologies affecting their mental health.
GENETIC CARRIER TEST
(RECESSIVE MONOGENIC DISEASES)
All OXX bank oocyte donors are subjected to the genetic test on recessive diseases in order to significantly minimise the risk of their transmission to any offspring.
The genetic test used is the qCarrier® Test (qGenomics), which, by means of NGS, analyses more than 4,000 mutations potentially responsible for around 300 recessive genetic diseases. The diseases analysed include cystic fibrosis, fragile X syndrome, spinal muscular atrophy, thalassemias, neonatal diabetes, congenital hypothyroidism, etc.
Upon the basis of the results obtained, we exclude oocyte donor candidates who are carriers of:
- Cystic fibrosis
- Diseases linked to the X chromosome (fragile X, haemophilia, etc.).
Our commitment and responsibility in retaining a blood sample of all the donors until two years after the last embryo transfer carried out with their oocytes.
- Rh factor (D)
- Blood group
- Ag HBs
- Ac HBs
- Ac HBc (IgG + IgM)
- CMV (IgG + IgM)
- HIV 1 + HIV 2
- Ac VHC
- HTLV I - II
- ALT / GPT
- ALT / GOT
- Total cholesterol
- Prothrombin time
This enables us to compare the genetic information of the oocyte donor and the data of the recipient’s male partner.
This genetic compatibility study compares more than 300 genetic diseases in order to prevent the transmission of these recessive monogenic diseases to any offspring.
All our donors are examined by the qCarrier® Test (qGenomics), but if the partner centre so requires, the donor may also undergo the genetic tests required in each specific case.